Assessing the Efficacy of Probiotics in Prevention of NEC in Preterm Babies
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
AgeUp to 1
SponsorHayatabad Medical Complex
About this trial
The goal of the study is to check efficacy of probiotics in preventing necrotizing enterocolitis. The main questions would be if the preterm baby developed NEC or not.
Eligibility criteria
Qualifiers
Male and female preterm infants with a gestational age less than 35 weeks.
All indoor patients and outdoor patients who present within 24hrs of birth
Disqualifiers
• Infants with congenital or developmental gastrointestinal disorders for example omphalocele, malrotation, gastroschisis.
Infants with severe sepsis or gastrointestinal bleeding on presentation
Trial design
Treatments tested in this trial
- Probiotic
- 10% dextrose
Treatment groups
196 Participants
are divided into 2 treatment groupsLocations
Sponsors and collaborators
Source ClinicalTrials.gov